Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

Noa Eliakim-Raz, Amir Massarweh, Amos Stemmer, Salomon M. Stemmer*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

38 Scopus citations
Original languageEnglish
Pages (from-to)1716-1718
Number of pages3
JournalJAMA Oncology
Volume7
Issue number11
DOIs
StatePublished - Nov 2021

Funding

FundersFunder number
Celldex Pharmaceuticals
Genentech
TG Therapeutics

    Cite this